descriptive
Analysis v1
Strong Opposition
The cholesterol-lowering drug atorvastatin doesn’t get into the fatty plaques in arteries — so it must be working by lowering cholesterol in the blood, not by directly touching the immune cells inside the plaque.
0
61
Evidence from Studies
Supporting (0)
0
Community contributions welcome
No supporting evidence found
Contradicting (1)
61
Community contributions welcome
61
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering
Cohort Study
Human
2020 Dec 9The study found that the drug atorvastatin doesn’t stick around in artery plaques, so it can’t be working directly there — instead, it lowers cholesterol in the blood, which then reduces plaque inflammation indirectly.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.